Keywords: fda, forces, label-change, amgen, anemia, drugs, usa

FDA forces label-change for Amgen anemia drugs

Article | 01 September 2008

Print This

The USA's Amgen has been made to change the labelling of its drugs Aranesp (darbepoetin alfa) and Procrit (epoetin alfa) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in